GLENMARKUpdated 1 Sept 2026, 2:39

Glenmark Pharmaceuticals

GLENMARKUpdated 1 Sept 2026, 2:39

Market Cap

₹69,992Cr.

Current Price

₹2,480

High / Low

₹2,538/1,793

Stock P/E

47.9

ROE3.87%

ROCE6.51%

Book Value₹856

Face Value₹1.00

Dividend Yield0.20%

About

Glenmark Pharmaceuticals Ltd is a global research-led pharmaceutical company with presence across generics, Specialty and OTC business with operations in over 80 countries.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	175	182	177	253	121	100	120	120	111	115	101	143
Inventory Days	161	182	172	195	141	115	94	102	117	130	156	153
Days Payable	343	306	221	273	258	217	201	208	225	307	249	326
Cash Conversion Cycle	-6	59	129	175	4	-3	14	14	3	-62	8	-30
Working Capital Days	79	108	170	232	151	106	115	42	29	12	55	92
ROCE %	33%	26%	29%	10%	13%	11%	12%	11%	11%	10%	10%	7%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 1 September 2026 at 2:39

GLENMARK PHARMACEUTICALS (GLENMARK) financials — quarterly results, P&L, cash flow, balance sheet, shareholding